Workflow
迈克生物(300463.SZ):2025年中报净利润为3404.25万元

Financial Performance - The company reported a total revenue of 1.075 billion yuan for the first half of 2025 [1] - The net profit attributable to shareholders was 34.0425 million yuan [1] - The net cash inflow from operating activities was 162 million yuan [1] Key Financial Ratios - The latest debt-to-asset ratio is 20.45% [3] - The gross profit margin is 56.96%, which is an increase of 0.20 percentage points compared to the previous quarter, marking two consecutive quarters of growth [3] - The return on equity (ROE) stands at 0.54% [3] - The diluted earnings per share (EPS) is 0.06 yuan [3] - The total asset turnover ratio is 0.13 times [3] - The inventory turnover ratio is 0.48 times [3] Shareholder Information - The number of shareholders is 35,000 [3] - The top ten shareholders hold a total of 252 million shares, accounting for 41.11% of the total share capital [3] - The top shareholders and their respective holdings are as follows: - Tang Yong: 11.1% - Wang Dengming: 7.43% - Guo Lei: 5.84% - Liu Qilin: 5.41% - Chen Mei: 4.30% - Wang Chuan Ying: 3.68% - Shanghai A Xing Investment Management Co., Ltd.: 1.02% - Hong Kong Central Clearing Limited: 0.84% - Xinhua Pension Tonghai Stable Progress No. 2 Stock-type Pension Product: 0.74% - Wang Xiaotao: 0.73% [3]